From: Studies of Health Insurance Claims Data in Japan: A Scoping Review
All | NDB | JMDC | MDV | DPC | NHI/LSEHS | JHIA | Other/Multiple | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | 1493 | % | 102 | % | 340 | % | 187 | % | 584 | % | 160 | % | 12 | % | 108 | % | |
Setting | National | 1267 | 84.9 | 97 | 95.1 | 339 | 99.7 | 187 | 100 | 567 | 97.1 | 2 | 1.3 | 2 | 16.7 | 73 | 67.6 |
Regional | 156 | 10.4 | 3 | 2.9 | 0 | 0.0 | 0 | 0.0 | 5 | 0.9 | 129 | 80.6 | 10 | 83.3 | 9 | 8.3 | |
Others | 70 | 4.7 | 2 | 2.0 | 1 | 0.3 | 0 | 0.0 | 12 | 2.1 | 29 | 18.1 | 0 | 0.0 | 26 | 24.1 | |
Age | Children | 94 | 6.3 | 7 | 6.9 | 33 | 9.7 | 7 | 3.7 | 39 | 6.7 | 3 | 1.9 | 0 | 0.0 | 5 | 4.6 |
Older persons | 134 | 9 | 10 | 9.8 | 9 | 2.6 | 4 | 2.1 | 29 | 5.0 | 80 | 50.0 | 0 | 0.0 | 2 | 1.9 | |
Others | 1265 | 84.7 | 85 | 83.3 | 298 | 87.6 | 176 | 94.1 | 516 | 88.4 | 77 | 48.1 | 12 | 100.0 | 101 | 93.5 |
From: Studies of Health Insurance Claims Data in Japan: A Scoping Review
Database | Age | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All | NDB | JMDC | MDV | DPC | NHI/LSEHS | JHIA | Other/Multiple | Children | Older persons | Others | ||||||||||||
Total | 1493 | % | 102 | % | 340 | % | 187 | % | 584 | % | 160 | % | 12 | % | 108 | % | 94 | % | 134 | % | 1265 | % |
1) Certain infectious and parasitic diseases | 117 | 7.8 | 15 | 14.7 | 29 | 8.5 | 16 | 8.6 | 41 | 7.0 | 4 | 2.5 | 0 | 0.0 | 12 | 11.1 | 14 | 14.9 | 0 | 0.0 | 103 | 8.1 |
2) Neoplasms | 162 | 10.9 | 6 | 5.9 | 22 | 6.5 | 31 | 16.6 | 92 | 15.8 | 4 | 2.5 | 3 | 25.0 | 4 | 3.7 | 2 | 2.1 | 2 | 1.5 | 158 | 12.5 |
3) Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | 19 | 1.3 | 0 | 0.0 | 0 | 0.0 | 3 | 1.6 | 15 | 2.6 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 4 | 4.3 | 0 | 0.0 | 15 | 1.2 |
4) Endocrine, nutritional, and metabolic diseases | 171 | 11.5 | 11 | 10.8 | 62 | 18.2 | 40 | 21.4 | 9 | 1.5 | 21 | 13.1 | 3 | 25.0 | 25 | 23.1 | 5 | 5.3 | 4 | 3.0 | 162 | 12.8 |
5) Mental, behavioral, and neurodevelopmental disorders | 110 | 7.4 | 13 | 12.7 | 47 | 13.8 | 2 | 1.1 | 22 | 3.8 | 13 | 8.1 | 3 | 25.0 | 10 | 9.3 | 6 | 6.4 | 13 | 9.7 | 91 | 7.2 |
6) Diseases of the nervous system | 69 | 4.6 | 4 | 3.9 | 18 | 5.3 | 10 | 5.3 | 24 | 4.1 | 7 | 4.4 | 0 | 0.0 | 6 | 5.6 | 3 | 3.2 | 9 | 6.7 | 57 | 4.5 |
7) Diseases of the eye and adnexa | 22 | 1.5 | 1 | 1.0 | 13 | 3.8 | 1 | 0.5 | 3 | 0.5 | 0 | 0.0 | 0 | 0.0 | 4 | 3.7 | 0 | 0.0 | 0 | 0.0 | 22 | 1.7 |
8) Diseases of the ear and mastoid process | 4 | 0.3 | 0 | 0.0 | 3 | 0.9 | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 3.2 | 0 | 0.0 | 1 | 0.1 |
9) Diseases of the circulatory system | 281 | 18.8 | 11 | 10.8 | 49 | 14.4 | 41 | 21.9 | 138 | 23.6 | 21 | 13.1 | 3 | 25.0 | 18 | 16.7 | 3 | 3.2 | 11 | 8.2 | 267 | 21.1 |
10) Diseases of the respiratory system | 135 | 9.0 | 11 | 10.8 | 38 | 11.2 | 10 | 5.3 | 56 | 9.6 | 13 | 8.1 | 0 | 0.0 | 7 | 6.5 | 24 | 25.5 | 22 | 16.4 | 89 | 7.0 |
11) Diseases of the digestive system | 115 | 7.7 | 6 | 5.9 | 24 | 7.1 | 8 | 4.3 | 61 | 10.4 | 11 | 6.9 | 1 | 8.3 | 4 | 3.7 | 6 | 6.4 | 8 | 6.0 | 101 | 8.0 |
12) Diseases of the skin and subcutaneous tissue | 17 | 1.1 | 2 | 2.0 | 9 | 2.6 | 1 | 0.5 | 3 | 0.5 | 1 | 0.6 | 0 | 0.0 | 1 | 0.9 | 3 | 3.2 | 1 | 0.7 | 13 | 1.0 |
13) Diseases of the musculoskeletal system and connective tissue | 93 | 6.2 | 7 | 6.9 | 25 | 7.4 | 16 | 8.6 | 36 | 6.2 | 5 | 3.1 | 0 | 0.0 | 4 | 3.7 | 5 | 5.3 | 7 | 5.2 | 81 | 6.4 |
14) Diseases of the genitourinary system | 75 | 5.0 | 4 | 3.9 | 15 | 4.4 | 9 | 4.8 | 34 | 5.8 | 7 | 4.4 | 1 | 8.3 | 5 | 4.6 | 1 | 1.1 | 5 | 3.7 | 69 | 5.5 |
15) Pregnancy, childbirth, and the puerperium | 25 | 1.7 | 4 | 3.9 | 9 | 2.6 | 1 | 0.5 | 11 | 1.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 25 | 2.0 |
16) Certain conditions originating in the perinatal period | 8 | 0.5 | 0 | 0.0 | 3 | 0.9 | 1 | 0.5 | 3 | 0.5 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 4 | 4.3 | 0 | 0.0 | 4 | 0.3 |
17) Congenital malformations, deformations, and chromosomal abnormalities | 13 | 0.9 | 0 | 0.0 | 3 | 0.9 | 1 | 0.5 | 8 | 1.4 | 0 | 0.0 | 0 | 0.0 | 1 | 0.9 | 11 | 11.7 | 0 | 0.0 | 2 | 0.2 |
18) Injury, poisoning, and certain other consequences of external causes | 110 | 7.4 | 11 | 10.8 | 9 | 2.6 | 3 | 1.6 | 77 | 13.2 | 9 | 5.6 | 0 | 0.0 | 1 | 0.9 | 7 | 7.4 | 22 | 16.4 | 81 | 6.4 |
19) Others (multidisease, not focused on specific diseases) | 238 | 15.9 | 21 | 20.6 | 41 | 12.1 | 21 | 11.2 | 69 | 11.8 | 68 | 42.5 | 0 | 0.0 | 18 | 16.7 | 16 | 17.0 | 50 | 37.3 | 172 | 13.6 |
From: Studies of Health Insurance Claims Data in Japan: A Scoping Review
All | NDB | JMDC | MDV | DPC | NHI/LSEHS | JHIA | Other/Multiple | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | 1493 | % | 102 | % | 340 | % | 187 | % | 584 | % | 160 | % | 12 | % | 108 | % |
Medical treatment status | 448 | 30.0 | 40 | 39.2 | 149 | 43.8 | 73 | 39.0 | 106 | 18.2 | 43 | 26.9 | 2 | 16.7 | 35 | 32.4 |
Intervention effect | 447 | 29.9 | 17 | 16.7 | 85 | 25.0 | 60 | 32.1 | 259 | 44.3 | 15 | 9.4 | 1 | 8.3 | 10 | 9.3 |
Clinical epidemiology, course of diseases | 417 | 27.9 | 33 | 32.4 | 92 | 27.1 | 50 | 26.7 | 187 | 32.0 | 36 | 22.5 | 4 | 33.3 | 15 | 13.9 |
Health economics | 211 | 14.1 | 10 | 9.8 | 47 | 13.8 | 43 | 23.0 | 42 | 7.2 | 44 | 27.5 | 3 | 25.0 | 22 | 20.4 |
Health policy evaluation and utilization | 186 | 12.5 | 9 | 8.8 | 23 | 6.8 | 8 | 4.3 | 78 | 13.4 | 49 | 30.6 | 4 | 33.3 | 15 | 13.9 |
Quality of care | 91 | 6.1 | 11 | 10.8 | 30 | 8.8 | 9 | 4.8 | 29 | 5.0 | 8 | 5.0 | 0 | 0.0 | 4 | 3.7 |
Research methodology | 77 | 5.2 | 15 | 14.7 | 12 | 3.5 | 6 | 3.2 | 22 | 3.8 | 6 | 3.8 | 0 | 0.0 | 16 | 14.8 |
Patient health service utilization | 76 | 5.1 | 1 | 1.0 | 31 | 9.1 | 6 | 3.2 | 3 | 0.5 | 16 | 10.0 | 2 | 16.7 | 17 | 15.7 |
Socioeconomic comparison | 56 | 3.8 | 8 | 7.8 | 7 | 2.1 | 2 | 1.1 | 14 | 2.4 | 17 | 10.6 | 2 | 16.7 | 6 | 5.6 |
Prediction model | 36 | 2.4 | 1 | 1.0 | 4 | 1.2 | 2 | 1.1 | 22 | 3.8 | 3 | 1.9 | 0 | 0.0 | 4 | 3.7 |
COVID-19 | 11 | 0.7 | 0 | 0.0 | 1 | 0.3 | 5 | 2.7 | 4 | 0.7 | 1 | 0.6 | 0 | 0.0 | 0 | 0.0 |
Others | 8 | 0.5 | 0 | 0.0 | 4 | 1.2 | 0 | 0.0 | 2 | 0.3 | 1 | 0.6 | 0 | 0.0 | 1 | 0.9 |
From: Studies of Health Insurance Claims Data in Japan: A Scoping Review
Medical treatment status | Diagnosis pattern |
Treatment pattern | |
Screening, test, monitoring (frequency, rate) | |
Prescription pattern | |
Hospitalization, readmission, NICU | |
Emergency medicine | |
Home-based care | |
Intervention effect | Effectiveness (treatment, prevention): surgery, procedures, drug, vaccine, periodontal management, follow-up, rehabilitation, health guidance, etc. |
Drug repositioning | |
Safety | |
Adverse outcomes | |
Clinical epidemiology, course of diseases | Prevalence, incidence, number of patients |
Association, risk factor, predictor, prognostic factor | |
Clinical characteristics (age, sex) | |
Comorbidity, underlying conditions | |
Mortality, survival, prognosis | |
Clinical course | |
Surveillance, seasonality, yearly change | |
Health economics | Cost-effectiveness |
Cost analysis | |
Factors associated with medical expenditure | |
Economic impact | |
Medical billing issues | |
Health policy evaluation and utilization | Health policy impact: medical subsidy, payment system, drug approval, regulatory action on drug, labeling change on prescriptions OTC switching, clinical guideline, information campaign, etc. |
Hospital performance | |
Volume-outcome relationship (other healthcare factors) | |
Supply and demand for healthcare | |
Post-marketing surveillance | |
Analysis of healthcare region | |
Use for healthcare planning | |
Evaluation of resource consumption | |
Analysis of home care service utilization | |
Quality of care | Adherence to clinical guideline |
Quality indicator | |
Safety indicator | |
Healthcare benchmarking | |
Research methodology | Validation study |
Comparison with other data sources | |
Patient traceability | |
Definition of death | |
Correction methods for medical fee revisions | |
Development of database | |
Development of indicator/algorithm | |
Patient health service utilization | Adherence, compliance, persistence |
Treatment initiation | |
Follow-up visits | |
Healthcare utilization | |
Healthcare-seeking behavior | |
Patient choice, selection | |
Socioeconomic comparison | Regional variations |
Age and sex distribution | |
Income-related inequality | |
Residence (home, care facilities) | |
Type of health insurance | |
International comparison | |
Prediction model | Predict survival/mortality |
Severe adverse events | |
Hospitalization | |
Comorbidity scores | |
High-need high-cost patients | |
Prediction model of infectious disease | |
COVID-19 | Trends in hospitalizations (NICU) during the COVID-19 outbreak |
Changes in intervention/care practice | |
Adverse events of COVID-19 vaccines | |
School closure and social distancing for COVID-19 | |
Economic impact of COVID-19 pandemic | |
Others | Effect of earthquakes |
Others |